How do you pay?

How to pay the least

Ask for the cash price

Xtampza ER

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you.

  1. Ask your pharmacy for Xtampza ER’s cash price, and one or two other pharmacies too.
  2. Xtampza ER’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameXtampza ER
Authorized genericoxycodone
Regular genericoxycodone
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Other forms onlyAsk your doctor
Same as Xtampza ER?
The original
–
–

Brand nameThe maker’s card

XTAMPZA ER Savings Card

Savings card from Collegium Pharmaceutical

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $35 a prescription

Print the card from xtampza.copaysavingsprogram.com 

See the offer on xtampzaer.com

In the maker’s words

“eligible patients may pay as little as $35 for each prescription.”

From the maker’s offer on xtampzaer.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Xtampza ER itself, from the same company, sold without the brand name, and usually for less. For now Xtampza ER is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

XTAMPZA ER is an opioid agonist indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids.

Limitations of Use

  • Because of the risks of addiction, abuse, misuse, overdose, and death,which can occur at any dosage or duration and persist over the course of therapy, reserve opioid analgesics, including XTAMPZA ER, for use in patients for whom alternative treatment optionsare ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.
  • XTAMPZA ER is not indicated as an as-needed (prn) analgesic.

Source: the FDA label for Xtampza ER (Collegium Pharmaceutical, Inc.), December 30, 2025. Full label on DailyMed 

Good to know